|
Market Cap (10-Jun) $83,592,392 (477th) |
Close (30-Jun) $0.99 |
Volume (30-Jun) 1,077,429 |
Shortsold (26-May) 45,932 (0.01%) (578th) |
|
52w High $0.480 |
52w Low $0.140 |
P/E 8.12 |
EPS -0.1 |
A news article has been posted about Paradigm Biopharmaceuticals on the AFR. The article was published around , on 13 March 2022 at 4:05pm.
Any Morgans clients who moved quickly on the retail broker’s advice to dump Paradigm Biopharmaceuticals must be ruing their timing.
Read ArticlePAR was $1.20 at the close of trade on 11 March 2022
| Recent Articles about ASX:PAR | |
|---|---|
| 9-Jun | Phase 3 OA Trial Continues Following Formal DSMB 20% Safety ...
company-announcements.afr.com |
| 3-Jun | Appendix 3H - Notification of cessation of securities - AFR
company-announcements.afr.com |
| 2-Jun | Appendix 2A - Application for quotation of securities - AFR
company-announcements.afr.com |
| 2-Jun | Appendix 3Y - AFR
company-announcements.afr.com |
| 1-Jun | Appendix 3B - Proposed issue of securities - AFR
company-announcements.afr.com |
| 1-Jun | Results of Oversubscribed Share Purchase Plan - AFR
company-announcements.afr.com |
| 7-May | Paradigm Confirms 50% of Patients Dosed in Phase 3 OA Trial ...
company-announcements.afr.com |
| 1-May | Notice under Section 708A(5)(e) of the Corporations Act 2001 (Cth)
company-announcements.afr.com |
| 1-May | Appendix 2A - Application for quotation of securities - AFR
company-announcements.afr.com |
| 1-May | Form 603 - AFR
company-announcements.afr.com |
| Tracked |
Find all articles about Paradigm Biopharmaceuticals, including others on the AFR, on the media page.
You must be logged in to post a reply.
Paradigm Biopharmaceuticals 